Tag Archive for: sexual health

Futura Medical extends collaboration with Cooper Consumer Health

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, today announces that it has extended until January 2029 its exclusive licensing agreement with Cooper Consumer Health (“Cooper”), a leading European independent self-care organisation, for the rights to commercialise Eroxon®, the Company’s topical, gel-based Erectile Dysfunction (“ED”) treatment, throughout the European […]

Read more

Futura Medical plc – Appointment of Roy Davis as Non-Executive Director

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, today announces the appointment of Roy Davis as a Non-Executive Director with immediate effect. Read more…

Read more

Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, is pleased to announce that M8 Pharmaceuticals, Inc (“M8”) has taken up its rights to extend its licensing agreement from Brazil and Mexico to market MED3000 in a further fourteen countries throughout the Central and South American region. Read more…

Read more

Futura Medical – Eroxon Awarded “New Product of the Year, Healthcare” by Boots

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, announces that Eroxon® has won the “New Product of the Year, Healthcare” category at the Boots Supplier Awards 2023, following its UK launch earlier this year. The award is further recognition for Futura’s breakthrough treatment for erectile dysfunction (“ED”) as it provides an […]

Read more

Futura Medical plc – Interim Results 2023

/in

Futura Medical plc (AIM: FUM), the pharmaceutical company developing innovative sexual health products, is pleased to announce its unaudited interim results for the six months ended 30 June 2023 (“H1 2023”). MED3000, under the brand name Eroxon®, is the first pan-European clinically proven topical treatment for Erectile Dysfunction (“ED”) available without the need of a doctor’s prescription […]

Read more